Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-19

Clinical Trial Update: The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis [NA]

View source ↗

Summary

A clinical trial examining whether intestinal microbiota dysbiosis, particularly involving Ruminococcus gnavus, contributes to the development of spondyloarthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Spondyloarthritis, Ruminococcus Gnavus | NA | Status: RECRUITING